Refine by MP, party, committee, province, or result type.
Health committee Little is planned in the laboratory. This brings up an important point: the value of technological or even drug-based innovations really only gets understood once they're in the health care system—and not necessarily funded as general funding, but partly funded as a research activity.
March 7th, 2013Committee meeting
Dr. David Jaffray
Health committee It's very similar to what was raised by Pascale in her comments. For health care, there's more technology in the world than we know what to do with. It's not matter of the next discovery. It's like raw material in terms of the capacity to bring new technologies forward, whether communication technologies or a novel intervention from a surgical perspective.
March 7th, 2013Committee meeting
Dr. David Jaffray
Health committee Thank you. I would like to thank the committee for this opportunity to share my perspective on the challenges of innovating in health care in Canada. I'll begin by introducing myself to the committee—it places my perspectives in context—and will follow with three specific messages I would like to bring to the committee's attention.
March 7th, 2013Committee meeting
Dr. David Jaffray